Clinical Trials for IDH1 Mutation

Find clinical trials for idh1 mutation. Discover research opportunities and treatment options in your area.

5 Active Trials Found

Showing 5 trials on this page

Page 1 of 1

Venetoclax and Ivosidenib Combined With Chemotherapy in IDH1 Mutated AML

NCT ID: NCT06611839

This clinical trial is investigating a new treatment approach for patients with acute myeloid leukemia (AML) who have a specific genetic mutation called IDH1. The researchers want to see how well a...

Not yet recruiting

Phase: PHASE1 Type: interventional

Olutasidenib, Venetoclax, and Azacitidine in IDH1 Mutated Newly Diagnosed Acute Myeloid Leukemia Patients Eligible for Intensive Induction Chemotherapy

NCT ID: NCT06782542

This clinical trial is exploring a new combination treatment for adults with a specific type of blood cancer called acute myeloid leukemia (AML) that has a mutation known as IDH1. The treatment bei...

Recruiting

Phase: PHASE2 Type: interventional Locations: Miami, Florida, United States

Study of Olutasidenib and Temozolomide in HGG

NCT ID: NCT06161974

This clinical trial is studying the effectiveness of a new treatment combining two drugs, olutasidenib and temozolomide, for young patients recently diagnosed with high-grade glioma (HGG) that has ...

Recruiting

Phase: PHASE2 Type: interventional Locations: Randwick, New South Wales, Australia, Cincinnati, Ohio, United States +18 more

Ivosidenib As Post-HSCT Maintenance for AML

NCT ID: NCT06707493

This clinical trial is studying a medication called ivosidenib, which is being tested as a treatment for patients with a specific type of blood cancer known as acute myeloid leukemia (AML) that has...

Not yet recruiting

Phase: PHASE2 Type: interventional Locations: Boston, Massachusetts, United States, Boston, Massachusetts, United States

Niraparib In Recurrent IDH 1/2 Gliomas

NCT ID: NCT05406700

This clinical trial is studying an experimental treatment called Niraparib for patients with recurrent low-grade gliomas that have specific gene mutations (IDH1 or IDH2). The goal is to understand ...

Recruiting

Phase: EARLY_PHASE1 Type: interventional Locations: Boston, Massachusetts, United States, Boston, Massachusetts, United States

Related Conditions

Breast Cancer View clinical trials → Stroke View clinical trials → Obesity View clinical trials → Cancer View clinical trials → Healthy View clinical trials → Prostate Cancer View clinical trials →

Search All Trials Browse All Conditions